Posted in M&A / Deals Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal April 20, 2026 BioSpace After entering the CAR T space in February, Eli Lilly is “jumping into in vivo CAR-T with both feet” with the acquisition of Kelonia Therapeutics and its gene delivery technology. M&A / DealsGene Therapy PlatformRead full story